I. Tavares Ladeira (Vila Nova de Gaia, Portugal), H. Kunst (London, United Kingdom), D. Chesov (Chisinau, Republic of Moldova), J. Cordeiro Da Costa (Leiria, Portugal)
Routine liver function test monitoring of patients treated for active M.TB infection does not influence management: A real-world retrospective study
E. Gosal (Nottingham, United Kingdom), A. Goodwin (Nottingham, United Kingdom), V. Navaratnam (Nottingham, United Kingdom), L. Dexter (Nottingham, United Kingdom), A. Rich (Nottingham, United Kingdom)
|  |
How does arginine effect on the course of tuberculosis? Experimental trial
I. Diachkov (Yekaterinburg, Russian Federation), I. Medvinskiy (Yekaterinburg, Russian Federation), E. Sabadash (Yekaterinburg, Russian Federation), S. Skornyakov (Yekaterinburg, Russian Federation), V. Kotomtsev (Yekaterinburg, Russian Federation), V. Pavlov (Yekaterinburg, Russian Federation), E. Ivanchikova (Yekaterinburg, Russian Federation)
| |
Determinants of lymph node resolution in patients of tubercular lymphadenitis treated with anti tuberculous chemotherapy.
A. Khurana (Bhopal, India), V. Gupta (Bhopal, India), D. Joshi (Bhopal, India), A. Goyal (Bhopal, India), K. Pawar (Bhopal, India), A. Pakhare (Bhopal, India)
| |
Mycobacterium tuberculosis resistance profiles in index and secondary TB cases from the same household
E. Chesov (Chisinau, Republic of Moldova), G. Balan (Chisinau, Republic of Moldova), N. Ciobanu (Chisinau, Republic of Moldova), D. Chesov (Chisinau, Republic of Moldova), V. Crudu (Chisinau, Republic of Moldova)
| |
Precision medicine in tuberculosis treatment – a role for pharmacogenetics?
M. da Silva Alcobia (Coimbra, Portugal), L. Nogueira (Coimbra, Portugal), M. Villar (Lisboa, Portugal), C. Robalo Cordeiro (Coimbra, Portugal), C. Fontes Ribeiro (Coimbra, Portugal), F. Regateiro (Coimbra, Portugal), H. Coimbra Silva (Coimbra, Portugal)
| |
EFFICACY OF SENSITIVE TUBERCULOSIS TREATMENT WITH MALABSORPTION SYNDROM DURING IV ADMINISTRATION OF ANTI-TUBERCULOSIS DRUGS
L. Todoriko (Chernivtsi, Ukraine), O. Podverbetskaya (Chernivtsi, Ukraine), N. Gumenyuk (Kyiv, Ukraine), M. Kuzhko (Kyiv, Ukraine), I. Sem?Aniv (Chernivtsi, Ukraine), O. Denisov (Kyiv, Ukraine), T. Sprynsian (Kyiv, Ukraine), I. Eremenchuk (Chernivtsi, Ukraine)
|  |
Lymph node tuberculosis: Criteria for cure and optimal duration of treatment
S. Alihalassa (Algiers, Algeria)
| |
Vitamin D levels in patients with active TB: Is it clinically relevant?
M. Jacobs (Nottingham, United Kingdom), E. Gosal (Nottingham, United Kingdom), A. Goodwin (Nottingham, United Kingdom), V. Navaratnam (Nottingham, United Kingdom), L. Dexter (Nottingham, United Kingdom), A. Rich (Nottingham, United Kingdom)
| |
TREATMENT OUTCOME OF THE RETREATMENT TUBERCULOSIS PATIENTS UNDER TUBERCULOSIS CONTROLE PROGRAMME IN A TB ENDEMIC PART OF INDIA
A. Mishra (GORAKHPUR, India), P. Gautam (GORAKHPUR, India), S. Kumar (AGRA, India)
| |
Fixed-dose combination antituberculosis therapy: is the INH dose adapted for the Tunisianpopulation?
A. Ben Tkhayat (Ariana, Tunisia), S. Ben Saad (Ariana, Tunisia), H. Daghfous (Ariana, Tunisia), F. Tritar (Ariana, Tunisia)
| |
Effectiveness of REBT psychotherapy approach on reducing cognitive distortions in tubercular patients
M. Safa (Tehran, Islamic Republic of Iran), P. Tabarsi (Tehran, Islamic Republic of Iran), F. Ghassem Boroujerdi (Tehran, Islamic Republic of Iran), B. Mirab Zadeh Ardekani (Tehran, Islamic Republic of Iran), F. Haji Zadeh (Tehran, Islamic Republic of Iran)
| |
Management of bronchopleural fistulas after pneumonectomy in tuberculosis patients by means of vascular occluders
A. Bazhenov (Ekaterinburg, Russian Federation), I. Motus (Ekaterinburg, Russian Federation), I. Medvinsky (Ekaterinburg, Russian Federation), A. Tsvirenko (Ekaterinburg, Russian Federation), R. Basyrov (Ekaterinburg, Russian Federation), L. Kardapoltsev (Ekaterinburg, Russian Federation), P. Holniy (Ekaterinburg, Russian Federation), I. Dotsenko (Ekaterinburg, Russian Federation), S. Skornyakov (Ekaterinburg, Russian Federation)
| |
High incidence of new onset joint pain in patients receiving fluoroquinolones as part of anti-tuberculous treatment
N. Agrawal (Mumbai, India), T. Lele (Mumbai, India), P. Vaidya (Mumbai, India), V. Chavhan (Mumbai, India), A. Taegtmeyer (Basel, Switzerland), J. Leuppi (Baselland, Switzerland), P. Chhajed (Mumbai, India)
| |
Function of the thyroid gland in patients with tuberculosis
a. polyakova (Moscow, Russian Federation), T. Bagdasaryan (Moscow, Russian Federation), M. Burakova (Moscow, Russian Federation), A. Tihonov (Moscow, Russian Federation), E. Atadzhan (Moscow, Russian Federation), R. Vladimir (Moscow, Russian Federation)
| |
Manifestations of hypersensitivity to anti-tuberculosis drugs
Y. BENBETKA (Algiers, Algeria), S. Souilah (Algiers, Algeria), A. Fissah (Algiers, Algeria)
| |
Frequency of adverse reactions to first-line anti-tuberculosis chemotherapy in patients with relapse(RTB)and newly diagnosed tuberculosis(NDTB)
D. Butov (Kharkiv, Ukraine), M. Kuzhko (Kiev, Ukraine), G. Stepanenko (Kharkiv, Ukraine), T. Butova (Kharkiv, Ukraine)
| |
Diagnosis and treatment of tuberculosis: what place is left for thoracic surgery?
S. ZAIRI (Tunis, Tunisia), S. Louhaichi (Tunis, Tunisia), A. Dridi (Tunis, Tunisia), M. Abdennadher (Tunis, Tunisia), H. Zribi (Tunis, Tunisia), H. Daghfous (Tunis, Tunisia), E. Brahem (Tunis, Tunisia), A. Ayadi (Tunis, Tunisia), S. Ouerghi (Tunis, Tunisia), F. Tritar (Tunis, Tunisia), F. Mezni (Tunis, Tunisia), A. Marghli (Tunis, Tunisia)
| |
Particular features of resumption of working capacity after resection of lungs in patients with destructive tuberculosis of lungs revealed for the first time
Y. Voloshyn (Kyiv, Ukraine), I. Kalabukha (Kyiv, Ukraine)
| |
Evaluation of hormones in the menstrual cycle of women with pulmonary tuberculosis
T. ASWATHY (jodhpur, India), G. Purohit (jodhpur, India), S. Vyas (jodhpur, India)
| |